Essential Thrombocytosis: A Rare Entity
Essential thrombocytosis is a chronic myeloproliferative disorder of unknown etiology, which is characterized by persistent megakaryocytic proliferation, resulting in markedly increased platelets in circulation. We present the case of a 40-year-old female patient, who came with complaints of excessi...
Saved in:
| Main Authors: | Parimi Ram Shashank, Intikabur Rahman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Assam Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ajoim.ajoim_25_22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS
by: E. G. lisina, et al.
Published: (2017-10-01) -
Essential thrombocytosis transformed AML with TP53 mutations and its clinical implications
by: Yang Si, et al.
Published: (2024-12-01) -
The characteristics of CALR mutations in myeloproliferative neoplasms: a clinical experience from a tertiary care center in Qatar and a literature review
by: Mostafa Najim, et al.
Published: (2024-12-01) -
Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center
by: Giulia Simini, et al.
Published: (2025-07-01) -
Analysis of MicroRNA -155-5p Expression in Patients with Primary Myelofibrosis.
by: Sarah I. Khaleel, et al.
Published: (2024-12-01)